当前位置: 首页 > 期刊 > 《华夏医学》 > 2008年第3期
编号:11644238
帕罗西汀治疗女性躯体化障碍的临床研究
http://www.100md.com 2008年6月1日 《华夏医学》 2008年第3期
帕罗西汀治疗女性躯体化障碍的临床研究

     摘要:目的:评价帕罗西汀对女性躯体化障碍患者的疗效和副 反应。方法:对28例女性躯体化障碍患者随机分为帕罗西汀组和文拉法辛组治疗6周,用汉 密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、不良反应量表(TESS)评定疗效和副反应 。结果:帕罗西汀与文拉法辛疗效相当,但其副反应轻,服用方便,依从性好。结论:帕罗 西汀治疗女性躯体化障碍患者疗效确切,值得推广使用。

    关键词:躯体化障碍;帕罗西汀;文拉法辛

    中图分类号: R749.053 文献标识码: A 文章编号: 1008-2409(2008)03-0431-02

    A comparative study of paroxetine in the treatment of woman somatization disorde r/XIE Xin-feng, DENG Shu-lu∥Long Quanshan Hospital, Liuzhou 545005, China

    Abstract: Objective: To compare the efficacy and side effects of par o xetine and venlafaxine in the treatment of woman somatization disorder. Methods:28 patients of woman somatization disorder were randomly assigned to paroxetinegroup and venlafaxine group for 6 weeks. Effects and side reactions were evalua t ed with HAMD and HAMA and TESS before and after treatment. Results: The therapeu ticefficacy in paroxetine group was similar to that in venlafaxine.The efficacy inparoxetine group had fewer side effects,taking conveniently and a good complian ce. Conclusion: Paroxetine is effective in the treatment of woman somatization d isorde. It is worthwhile generalization and use. ......

您现在查看是摘要页,全文长 4984 字符